231 related articles for article (PubMed ID: 18567863)
1. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
[TBL] [Abstract][Full Text] [Related]
2. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia.
Berrih-Aknin S; Ruhlmann N; Bismuth J; Cizeron-Clairac G; Zelman E; Shachar I; Dartevelle P; de Rosbo NK; Le Panse R
Ann Neurol; 2009 Oct; 66(4):521-31. PubMed ID: 19847900
[TBL] [Abstract][Full Text] [Related]
3. Central role of interferon-beta in thymic events leading to myasthenia gravis.
Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
[TBL] [Abstract][Full Text] [Related]
4. [Role of the thymus in the physiopathology of myasthenia].
Eymard B; Berrih-Aknin S
Rev Neurol (Paris); 1995 Jan; 151(1):6-15. PubMed ID: 7676132
[TBL] [Abstract][Full Text] [Related]
5. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia.
Shiao YM; Lee CC; Hsu YH; Huang SF; Lin CY; Li LH; Fann CS; Tsai CY; Tsai SF; Chiu HC
J Neuroimmunol; 2010 Apr; 221(1-2):101-6. PubMed ID: 20223524
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
[TBL] [Abstract][Full Text] [Related]
7. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
Hohlfeld R; Wekerle H
J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
[TBL] [Abstract][Full Text] [Related]
8. Thymic remodeling associated with hyperplasia in myasthenia gravis.
Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
[TBL] [Abstract][Full Text] [Related]
9. Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.
Truffault F; de Montpreville V; Eymard B; Sharshar T; Le Panse R; Berrih-Aknin S
Clin Rev Allergy Immunol; 2017 Feb; 52(1):108-124. PubMed ID: 27273086
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
11. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
12. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
Graus YF; de Baets MH; Parren PW; Berrih-Aknin S; Wokke J; van Breda Vriesman PJ; Burton DR
J Immunol; 1997 Feb; 158(4):1919-29. PubMed ID: 9029134
[TBL] [Abstract][Full Text] [Related]
13. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.
Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S
J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842
[TBL] [Abstract][Full Text] [Related]
14. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Reinhardt C; Melms A
Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
[TBL] [Abstract][Full Text] [Related]
15. Characterization of thymus cells in hyperplastic thymuses in patients with myasthenia gravis and ulcerative colitis with monoclonal antibodies.
Aiso S; Yoshida T; Watanabe M; Hibi T; Asakura H; Tsuchiya M; Tsuru S
J Clin Lab Immunol; 1984 Mar; 13(3):137-9. PubMed ID: 6609240
[TBL] [Abstract][Full Text] [Related]
16. Thymus involvement in early-onset myasthenia gravis.
Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R
Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185
[TBL] [Abstract][Full Text] [Related]
17. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
[TBL] [Abstract][Full Text] [Related]
18. [Thymic abnormalities in patients with myasthenia gravis].
Utsugisawa K; Nagane Y
Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138
[TBL] [Abstract][Full Text] [Related]
19. Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis.
Zhang J; Cohen-Kaminsky S; Berrih-Aknin S
Hum Antibodies Hybridomas; 1995; 6(4):153-60. PubMed ID: 8688498
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunizing mechanisms in thymoma and thymus.
Willcox N; Leite MI; Kadota Y; Jones M; Meager A; Subrahmanyam P; Dasgupta B; Morgan BP; Vincent A
Ann N Y Acad Sci; 2008; 1132():163-73. PubMed ID: 18567866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
